Find Ipragliflozin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

VMF

NDC API

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 761423-87-4, Suglat, Asp-1941, Asp1941, Ipragliflozin [inn], (2s,3r,4r,5s,6r)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
Molecular Formula
C21H21FO5S
Molecular Weight
404.5  g/mol
InChI Key
AHFWIQIYAXSLBA-RQXATKFSSA-N
FDA UNII
3N2N8OOR7X

Ipragliflozin
Ipragliflozin is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2.
1 2D Structure

Ipragliflozin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S,3R,4R,5S,6R)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
2.1.2 InChI
InChI=1S/C21H21FO5S/c22-15-6-5-12(21-20(26)19(25)18(24)16(10-23)27-21)7-13(15)9-14-8-11-3-1-2-4-17(11)28-14/h1-8,16,18-21,23-26H,9-10H2/t16-,18-,19+,20-,21+/m1/s1
2.1.3 InChI Key
AHFWIQIYAXSLBA-RQXATKFSSA-N
2.1.4 Canonical SMILES
C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)F
2.1.5 Isomeric SMILES
C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)F
2.2 Other Identifiers
2.2.1 UNII
3N2N8OOR7X
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (1s)-1,5-anhydro-1-(3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl)-d-glucitol

2. Asp-1941

3. Asp1941

4. Suglat

2.3.2 Depositor-Supplied Synonyms

1. 761423-87-4

2. Suglat

3. Asp-1941

4. Asp1941

5. Ipragliflozin [inn]

6. (2s,3r,4r,5s,6r)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

7. Ipragliflozin (asp1941)

8. 3n2n8oor7x

9. Chembl2018096

10. (1s)-1,5-anhydro-1-c-[3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl]-d-glucitol

11. Ipragliflozin (inn)

12. (1s)-1,5-anhydro-1-c-(3-((1-benzothiophen-2-yl)methyl)-4-fluorophenyl)-d-glucitol

13. Asp 1941

14. Unii-3n2n8oor7x

15. Ipragliflozin-l-proline

16. Ipragliflozin [mi]

17. (2s,3r,4r,5s,6r)-2-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol

18. Schembl337645

19. Ipragliflozin [who-dd]

20. Gtpl9394

21. Chebi:134724

22. Dtxsid701032738

23. Amy38779

24. Ex-a2770

25. Bdbm50381554

26. Mfcd19443744

27. S8637

28. Zinc38897728

29. Akos025405258

30. Ccg-268693

31. Db11698

32. Ncgc00378606-02

33. Ac-29008

34. As-39358

35. Hy-14894

36. D10196

37. Q17193526

38. (1s)-1,5-anhydro-1-(3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl)-d-glucitol

39. (1s)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)-4-fluorophenyl]-d-glucitol

40. (1s)-1,5-anhydro-1-c-[3-(1-benzothiophene-2-ylmethyl)-4-fluorophenyl]-d-glucitol

41. D-glucitol,1,5-anhydro-1-c-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-, (1s)-

42. (2s,3r,4r,5s,6r)-2-{3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl}-6-(hydroxymethyl)oxane-3,4,5-triol

43. D-glucitol, 1,5-anhydro-1-c-(3-(benzo(b)thien-2-ylmethyl)-4-fluorophenyl)-, (1s)-

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 404.5 g/mol
Molecular Formula C21H21FO5S
XLogP32.5
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count4
Exact Mass404.10937310 g/mol
Monoisotopic Mass404.10937310 g/mol
Topological Polar Surface Area118 Ų
Heavy Atom Count28
Formal Charge0
Complexity525
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Sodium-Glucose Transporter 2 Inhibitors

Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS. (See all compounds classified as Sodium-Glucose Transporter 2 Inhibitors.)


4.2 ATC Code

A - Alimentary tract and metabolism

A10 - Drugs used in diabetes

A10B - Blood glucose lowering drugs, excl. insulins

A10BK - Sodium-glucose co-transporter 2 (sglt2) inhibitors

A10BK05 - Ipragliflozin


Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Looking for 761423-87-4 / Ipragliflozin API manufacturers, exporters & distributors?

Ipragliflozin manufacturers, exporters & distributors 1

52

PharmaCompass offers a list of Ipragliflozin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ipragliflozin manufacturer or Ipragliflozin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ipragliflozin manufacturer or Ipragliflozin supplier.

PharmaCompass also assists you with knowing the Ipragliflozin API Price utilized in the formulation of products. Ipragliflozin API Price is not always fixed or binding as the Ipragliflozin Price is obtained through a variety of data sources. The Ipragliflozin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ipragliflozin

Synonyms

761423-87-4, Suglat, Asp-1941, Asp1941, Ipragliflozin [inn], (2s,3r,4r,5s,6r)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

Cas Number

761423-87-4

Unique Ingredient Identifier (UNII)

3N2N8OOR7X

About Ipragliflozin

Ipragliflozin is under investigation in Type 2 Diabetes and Diabetes Mellitus, Type 2.

suglat Manufacturers

A suglat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of suglat, including repackagers and relabelers. The FDA regulates suglat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. suglat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of suglat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

suglat Suppliers

A suglat supplier is an individual or a company that provides suglat active pharmaceutical ingredient (API) or suglat finished formulations upon request. The suglat suppliers may include suglat API manufacturers, exporters, distributors and traders.

click here to find a list of suglat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

suglat USDMF

A suglat DMF (Drug Master File) is a document detailing the whole manufacturing process of suglat active pharmaceutical ingredient (API) in detail. Different forms of suglat DMFs exist exist since differing nations have different regulations, such as suglat USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A suglat DMF submitted to regulatory agencies in the US is known as a USDMF. suglat USDMF includes data on suglat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The suglat USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of suglat suppliers with USDMF on PharmaCompass.

suglat KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a suglat Drug Master File in Korea (suglat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of suglat. The MFDS reviews the suglat KDMF as part of the drug registration process and uses the information provided in the suglat KDMF to evaluate the safety and efficacy of the drug.

After submitting a suglat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their suglat API can apply through the Korea Drug Master File (KDMF).

click here to find a list of suglat suppliers with KDMF on PharmaCompass.

suglat NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing suglat as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for suglat API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture suglat as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain suglat and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a suglat NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of suglat suppliers with NDC on PharmaCompass.

suglat GMP

suglat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of suglat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right suglat GMP manufacturer or suglat GMP API supplier for your needs.

suglat CoA

A suglat CoA (Certificate of Analysis) is a formal document that attests to suglat's compliance with suglat specifications and serves as a tool for batch-level quality control.

suglat CoA mostly includes findings from lab analyses of a specific batch. For each suglat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

suglat may be tested according to a variety of international standards, such as European Pharmacopoeia (suglat EP), suglat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (suglat USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty